
Join to View Full Profile
830 S Gloster StFl 4Tupelo, MS 38801
Phone+1 662-377-7170
Dr. Garner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Alabama Medical CenterResidency, Thoracic Surgery - Independent, 2013 - 2022
- Medical College of Georgia at Augusta UniversityClass of 2013
Certifications & Licensure
- MS State Medical License 2022 - 2025
- AL State Medical License 2014 - 2022
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Publications & Presentations
PubMed
- 3 citationsEarly outcomes following transatrial transcatheter mitral valve replacement in patients with severe mitral annular calcification.Michael I Brener, Mohanad Hamandi, Estee Hong, Alejandro Pizano, Morgan T Harloff
The Journal of Thoracic and Cardiovascular Surgery. 2024-04-01 - 3 citationsUAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line XenograftsAdele P. Williams, Evan F. Garner, Laura L. Stafman, Jamie M. Aye, Colin H. Quinn
Translational Oncology. 2019-10-01 - 4 citationsThe effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms t...Jamie M. Aye, Laura L. Stafman, Adele P. Williams, Evan F. Garner, Jerry E. Stewart
Oncotarget. 2019-09-17
Journal Articles
- UAB30, a Novel RXR Agonist, Decreases Tumorigenesis and Leptomeningeal Disease in Group 3 Medulloblastoma Patient-Derived XenograftsGregory K Friedman, Evan F Garner, Laura L Stafman, Journal of Neuro-Oncology
Press Mentions
- | Newsmakers |July 30th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: